切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2016, Vol. 10 ›› Issue (06) : 358 -361. doi: 10.3877/cma.j.issn.1674-0807.2016.06.007

综述

乳腺癌前哨淋巴结活组织检查在基层医院应用的可行性分析
谢凤鸣1,2, 孙强1,(), 彭旭光2, 周易冬1, 茅枫1, 关竞红1, 林燕1, 沈松杰1, 潘博1   
  1. 1.100730 中国医学科学院北京协和医院乳腺外科
    2.661100 云南省红河哈尼族彝族自治州第一人民医院普外科
  • 收稿日期:2015-12-15 出版日期:2016-12-01
  • 通信作者: 孙强
  • 基金资助:
    国家“十二五”科技支撑计划项目(2014BAI08B00)

Feasibility analysis of sentinel lymph node biopsy in breast cancer in primary hospitals

Fengming Xie, Qiang Sun(), Xuguang Peng, Yidong Zhou, Fen Mao, Jinghong Guan, Yan Lin, Gongjie Sheng, Bbo Pan   

  • Received:2015-12-15 Published:2016-12-01
  • Corresponding author: Qiang Sun
引用本文:

谢凤鸣, 孙强, 彭旭光, 周易冬, 茅枫, 关竞红, 林燕, 沈松杰, 潘博. 乳腺癌前哨淋巴结活组织检查在基层医院应用的可行性分析[J/OL]. 中华乳腺病杂志(电子版), 2016, 10(06): 358-361.

Fengming Xie, Qiang Sun, Xuguang Peng, Yidong Zhou, Fen Mao, Jinghong Guan, Yan Lin, Gongjie Sheng, Bbo Pan. Feasibility analysis of sentinel lymph node biopsy in breast cancer in primary hospitals[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2016, 10(06): 358-361.

乳腺癌是全世界女性最常见恶性肿瘤,严重危害妇女的健康。 腋窝淋巴结受累情况为乳腺癌重要的预后因素。 前哨淋巴结活组织检查(SLNB)可减少腋窝淋巴结清扫(ALND)术后并发症,并可准确评估腋窝淋巴结临床阴性乳腺癌患者的淋巴结转移状态,已成为乳腺癌的规范化手术之一,并被广泛用于乳腺癌腋窝淋巴结的分期诊断。 目前,SLNB 在技术较为成熟的乳腺外科团队已取得较为满意的成功率和假阴性率,但其在基层医院的推广仍面临一定困难,尤其是前哨淋巴结相关定位技术,对操作技巧及术者经验都有较高的要求。 笔者就SLNB 在早期乳腺癌治疗中临床应用的最新进展作一综述,并探讨SLNB 在基层医院应用的可行性。

[1]
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 [J]. Int J Cancer,2015,136(5):E359-386.
[2]
Banerjee M, George J, Song EY, et al. Tree-based model for breast cancer prognostication [J]. J Clin Oncol,2004,22(13):2567-2575.
[3]
Mastrangelo S,McMasters K, Ajkay N. Surgical management of the axilla in breast cancer[J]. Am Surg,2016,82(6):475-486.
[4]
Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J]. J Clin Oncol, 2005,23(30):7703-7720.
[5]
Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes[J]. Lancet,1997,349(9069):1864-1867.
[6]
Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial[J]. Lancet Oncol,2010,11(10):927-933.
[7]
Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J]. J Clin Oncol,2005,23(30):7703-7720.
[8]
Gradishar WJ, Anderson BO, Balassanian R, et al. Breast cancer version 2.2015[J]. J Natl Compr Canc Netw,2015,13(4):448-475.
[9]
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2013 版)[J].中国癌症杂志,2013,23(8):637-693.
[10]
刘奇,左文述,王永胜,等. 乳腺癌哨位淋巴结临床意义的研究[J].肿瘤防治杂志,2000,7(3):247-253.
[11]
任俊玲,陈斌,王亚兵. 早期乳腺癌前哨淋巴结活检在简化腋清扫中的应用研究[J]. 肿瘤学杂志,2014,20(8):677-680.
[12]
葛荣忠,任船,葛鹏宇.基层医院开展乳腺癌前哨淋巴结活检的体会[J].中国实用医药,2015,10(24):80-81.
[13]
Fattahi AS, Tavassoli A, Rohbakhshfar O, et al. Can mehylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery? [J]. J Res Med Sci,2014,19(10):918-922.
[14]
葛洁,颜博,曹旭晨. 纳米炭混悬注射液与亚甲蓝注射液在早中期乳腺癌前哨淋巴结活检中的应用[J].中华肿瘤杂志,2011,33(3):226-228.
[15]
关毅,郭文斌,高伟,等. 纳米碳对乳腺癌腋窝前哨淋巴结活检的应用价值[J]. 中国现代药物应用,2013,7(5):1-2.
[16]
Garbay JR, Skalli-Chrisostome D, Leymarie N, et al. The role of blue dye in sentinel node detection for breast cancer: A retrospective study of 203 patients[J]. Breast Care (Basel),2016,11(2):128-132.
[17]
Bakhtiar N, Jaleel F, Moosa FA, et al. Sentinel lymph node identification by blue dye in patients with breast carcinoma[J]. Pak J Med Sci,2016,32(2):448-451.
[18]
韩猛虎,姜合作,张建华,等. 早期乳腺癌前哨淋巴结活检的研究现状与实践[J]. 中国综合临床,2013,29(7):701-705.
[19]
Zhang X, Li Y, Zhou Y, et al.Diagnostic performance of indocyanine green-guided sentinel lymph node biopsy in breast cancer: a metaanalysis[J]. PLoS One,2016,11(6):e0155597.
[20]
Guo W, Zhang L, Ji J, et al. Breast cancer sentinel lymph node mapping using near-infrared guided indocyanine green in comparison with blue dye[J]. Tumour Biol,2014,35(4):3073-3078.
[21]
Hirche C, Murawa D, Mohr Z,et al. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer[J]. Breast Cancer Res Treat,2010,121(2):373-378.
[22]
Xiong L,Gazyakan E,Yang W, et al. Indocyanine green fluorescenceguided sentinel node biopsy: a meta-analysis on detection rate and diagnostic performance[J]. Eur J Surg Oncol, 2014, 40(7): 843-849.
[23]
Chi C, Ye J,Ding H,et al. Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation[J].PLoS One,2013,8(12): e83927.
[24]
Gawlick U, Mone MC, Nelson ET, et al. Success in sentinel lymph node procedures in obese patients with breast cancer[J]. Am J Surg,2010,200(6):707-710.
[25]
钟丽瑶,周平,李瑞珍. 经皮下注射超声造影剂在乳腺癌前哨淋巴结诊断中的价值[J]. 中华超声影像学杂志,2007,16(9):770-772.
[26]
Samorani D,Fogacci T, Panzini I, et al. The use of indocyanine green to detect sentinel nodes in breast cancer:a prospective study[J]. Eur J Surg Oncol,2015,41(1):64-70.
[27]
Jung SY, Kim SK, Kim SW, et al. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope,and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial[J]. Ann Surg Oncol,2014,21(4):1254-1259.
[28]
曹迎明,王殊,郭嘉嘉,等. 吲哚菁绿联合美蓝在乳腺癌前哨淋巴结活检术中的应用[J]. 中华普通外科杂志,2014,29(2):119-122.
[29]
Wishart GC, Loh SW, Jones L, et al. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer[J]. Eur J Surg Oncol, 2012,38(8):651-656.
[30]
Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update[J]. J Clin Oncol, 2014,32(13):1365-1383.
[31]
Inoue T, Nishi T, Nakano Y, et al. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer[J]. Breast Cancer,2016,23(2):295-300.
[32]
Guo W, Zhang L, Ji J, et al. Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer[J]. World J Surg Oncol,2014,12(1):290.
[1] 王佳佳, 詹韵韵, 姜凡, 孙碧云, 毕玉, 李如冰, 彭梅. Peyton四步教学法在超声住院医师规范化培训颈部淋巴结分区中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 814-818.
[2] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[8] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[9] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[10] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[13] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
阅读次数
全文


摘要